Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1527590 | 0.97 | CYP1A2 (0.31) | — | |
| SCHEMBL11260353 | 0.92 | TSHR (0.33) | TSHR | |
| SCHEMBL15572200 | 0.90 | TSHR (0.38) | LMNATSHR | |
| SCHEMBL8590656 | 0.90 | TSHR (0.32) | TSHR | |
| SCHEMBL6673774 | 0.90 | TSHR (0.38) | LMNATSHR | |
| SCHEMBL1258373 | 0.90 | TSHR (0.38) | LMNATSHR | |
| SCHEMBL8026449 | 0.88 | TSHR (0.36) | LMNATSHR | |
| SCHEMBL50152 | 0.88 | TSHR (0.36) | LMNATSHR | |
| SCHEMBL7398423 | 0.88 | TSHR (0.36) | LMNATSHR | |
| SCHEMBL9876888 | 0.87 | TSHR (0.33) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4188585-B1 | METHOD OF PRODUCING CARBON MOLECULAR SIEVE MEMBRANES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-19 | — | — | EP | claimed |
| US-12472482-B2 | Method of producing carbon molecular sieve membranes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-18 | — | — | US | claimed |
| US-20230278006-A1 | METHOD OF PRODUCING CARBON MOLECULAR SIEVE MEMBRANES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-09-07 | — | — | US | claimed |
| EP-4188585-A1 | METHOD OF PRODUCING CARBON MOLECULAR SIEVE MEMBRANES | Dow Global Technologies LLC (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2022026136-A1 | METHOD OF PRODUCING CARBON MOLECULAR SIEVE MEMBRANES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-02-03 | — | — | WO | claimed |
| WO-2014179673-A1 | PROCESSES FOR PURIFYING A CELLULOSIC MATERIAL | CELANESE INTERNATIONAL CORPORATION (US) | 2014-11-06 | — | — | WO | claimed |
| US-20140326421-A1 | Processes for Purifying a Cellulosic Material | CELANESE INTERNATIONAL CORPORATION (US) | 2014-11-06 | — | — | US | claimed |
| US-8632816-B2 | Compositions comprising solid particles entrapped in collapsed polymeric microspheres, and methods of making the same | ELC MANAGEMENT, LLC (US) | 2014-01-21 | — | — | US | claimed |
| US-20130071453-A1 | Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same | ELC MANAGEMENT LLC | 2013-03-21 | — | — | US | claimed |
| EP-4188585-B1 | METHOD OF PRODUCING CARBON MOLECULAR SIEVE MEMBRANES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-19 | — | — | EP | disclosed |
| US-12472482-B2 | Method of producing carbon molecular sieve membranes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-18 | — | — | US | disclosed |
| US-20230278006-A1 | METHOD OF PRODUCING CARBON MOLECULAR SIEVE MEMBRANES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230167545-A1 | STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C2H2 | LAM RESEARCH CORPORATION | 2023-06-01 | — | — | US | disclosed |
| CN-115989077-A | Solution of sulfone polymer in N-tert-butyl-2-pyrrolidone for membranes | 巴斯夫欧洲公司 | 2023-04-18 | — | — | CN | disclosed |
| WO-2014179673-A1 | PROCESSES FOR PURIFYING A CELLULOSIC MATERIAL | CELANESE INTERNATIONAL CORPORATION (US) | 2014-11-06 | — | — | WO | disclosed |
| WO-2014031667-A1 | METHODS FOR REMOVING HEMICELLULOSE | CELANESE INTERNATIONAL CORPORATION (US) | 2014-02-27 | — | — | WO | disclosed |
| US-8632816-B2 | Compositions comprising solid particles entrapped in collapsed polymeric microspheres, and methods of making the same | ELC MANAGEMENT, LLC (US) | 2014-01-21 | — | — | US | disclosed |
| US-20130071453-A1 | Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same | ELC MANAGEMENT LLC | 2013-03-21 | — | — | US | disclosed |
| US-20070293538-A1 | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders | MYRIAD GENETICS, INCORPORATED (US) | 2007-12-20 | — | — | US | disclosed |
| WO-2006001877-A2 | COMBINATION TREATMENT FOR NEURODEGENERATIVE DISORDERS COMPRISING R-FLURBIPROFEN | MYRIAD GENETICS, INC. (US) | 2006-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293538-A1 | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders | GRN, NLN, PSEN1 | LMNA 1156/4885TSHR 4583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.